Suzhou-based BrightGene raises pre-IPO round

BrightGene Bio-Medical Technology Co. Ltd. (Suzhou, China) raised RMB550 million ($80.3 million) in a venture round. The company described the funding as a "pre-IPO round," but did not immediately respond to an inquiry about its plans for a listing.

Sequoia Capital China and HighLight Capital led the round, with additional participation by GF Qianhe...